Mounjaro is an antidiabetic drug which has boomed in popularity because of how it works as an appetite suppressant. It’s ...

Presenting results from the REDEFINE 1 and REDEFINE 2 studies at the American Diabetes Association (ADA) congress in Chicago, ...

Canadian study reveals diabetic patients taking GLP-1 medications face twice the risk of eye problems, with longer exposure ...

With weight-loss injections like Semaglutide gaining popularity, experts warn they’re not a one-size-fits-all fix. We got in touch with an expert who explains why long-term success lies in combining ...

A new oral anti-diabetes pill, orforglipron, shows similar effectiveness to injectable GLP-1 drugs in a Phase 3 trial.

The mass rollout of weight loss jabs such as Mounjaro on the NHS in England will begin today as GPs are allowed to prescribe the drugs for the ...

The Ohio Board of Pharmacy has suspended four more distribution licenses, accusing two med spas and two doctor's offices of ...

But as of today, Monday, June 23, GPs in England will be able to prescribe weight loss jabs for the first time on the NHS, as ...

Prescriptions for Mounjaro jabs, to help people lose weight, will be available at GP surgeries in England from today - but ...

A major change in the rules starts on Monday and you must have four medical conditions as well as a specific BMI ...

The mass rollout of weight loss jabs on the NHS in England started on Monday, with GPs now allowed to prescribe the drugs for the first time. Around 220,000 people with “greatest need” are expected to ...

The mass rollout of the drugs on the NHS in England will begin on Monday (June 23) as GPs are allowed to prescribe weight ...